2016 VAM: 1201 - Allergen Immunotherapy, Today and Tomorrow: Session II. Immunotherapy with Food Allergens
This course will summarize the state of the art of allergen immunotherapy for food allergy, including new observations on immunologic changes associated with food allergen immunotherapy and includes a special emphasis on inducing long-term prevention of peanut allergy by early life exposure to allergen. The course will also discuss differences in approaches to immunotherapy for food vs. inhalant allergens.
AMA PRA Category 1 Credits™: 2.50
Credit must be claimed by May 31, 2018. Any credit request on or after June 1, 2018 will be subject to an administrative fee.
Allied Health Professionals
Upon completion of this session, participants should be able to:
1. Discuss current and future approaches to allergen immunotherapy for food allergy
2. Discuss the potential mechanisms by which immunotherapy modulates the immune response to allergens
3. Discuss the durability of immune unresponsiveness induced by allergen immunotherapy or by ingestion of food allergens beginning in infancy
Cecilia Berin, PhD, Icahn School of Medicine at Mount Sinai, New York, NY
Stacie M. Jones, MD, University of Arkansas for Medical Sciences, Little Rock, AR
Gideon Lack, MD, St Thomas' Hospital, London, United Kingdom
Kari C. Nadeau, MD PhD FAAAAI, Stanford University School Medicine, Stanford, CA
Brian P. Vickery, MD FAAAAI, University of North Carolina, Chapel Hill, NC
- 2.50 AttendanceAttendance credit.
- 2.50 CECE credit.
- 2.50 CMECME credit.